The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CeNtuRIOn: Rucaparib (R) with nivolumab (N) and ipilimumab (I) in patients (pts) with relapsed ovarian cancer (ROC)—Results of an initial safety cohort.
 
Marcia Hall
Honoraria - Clovis Oncology; GlaxoSmithKline
Consulting or Advisory Role - Clovis Oncology; GlaxoSmithKline
Research Funding - BMS (Inst); Clovis Oncology (Inst); Merck (Inst)
 
Karen Allan
No Relationships to Disclose
 
Agnieszka Michael
No Relationships to Disclose
 
Andrew R. Clamp
Consulting or Advisory Role - AstraZeneca; Eisai Europe; GlaxoSmithKline
Speakers' Bureau - Clovis Oncology
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Immunogen (Inst); Merck (Inst); Pfizer (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Tesaro
 
Rosalind Glasspool
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; ImmunoGen
Speakers' Bureau - Clovis Oncology
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); Ignyta (Inst); ImmunoGen (Inst); Pfizer (Inst); Roche (Inst)
 
Shibani Nicum
Research Funding - AstraZeneca (Inst)
 
Rosemary Lord
Research Funding - AstraZeneca (Inst)
 
Susana N. Banerjee
Honoraria - Amgen; AstraZeneca; Clovis Oncology; GlaxoSmithKline; Immunogen; Mersana; MSD Oncology; Pfizer; Roche; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; GenMab; GlaxoSmithKline; Immunogen; Merck Serono; Mersana; MSD Oncology; OncXerna Therapeutics; Seagen; Shattuck Labs
Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst)
 
Joshua Roche
No Relationships to Disclose
 
Jamie Stobo
No Relationships to Disclose
 
Charlie Gourley
Honoraria - AstraZeneca; Clovis Oncology; Cor2Ed; GlaxoSmithKline; MSD Oncology; Tesaro
Consulting or Advisory Role - AstraZeneca; Cor2Ed; GlaxoSmithKline; MSD Oncology; Nucana (Inst); Sierra Oncology; Tesaro (Inst)
Research Funding - Aprea AB (Inst); AstraZeneca (Inst); GlaxoSmithKline (Inst); MSD Oncology (Inst); Nucana (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - One patent issued and four pending for a gene expression signature to predict cancer sensitivity to anti-angiogenic therapy. (Inst)
Expert Testimony - Amgen